生化产品制造
Search documents
玮俊生物科技(00660.HK)年度收入约3.77亿港元 同比增加约1.9%
Ge Long Hui· 2025-09-30 15:11
Core Viewpoint - Wei Jun Biotechnology (00660.HK) reported a revenue of approximately HKD 377 million for the fiscal year ending June 30, 2025, representing an increase of about 1.9% compared to the previous year. The company also improved its net loss to approximately HKD 14.6 million from HKD 44.2 million in the prior year, primarily due to a significant reduction in impairment losses on non-financial assets [1]. Financial Performance - The group's revenue and gross profit remained relatively stable compared to the previous year, with a reported revenue of approximately HKD 377 million [1]. - The net loss for the fiscal year ending June 30, 2025, was approximately HKD 14.6 million, a significant improvement from the net loss of approximately HKD 44.2 million for the fiscal year ending June 30, 2024 [1]. - The improvement in net loss was mainly attributed to a substantial decrease in impairment losses on non-financial assets during the reporting period [1]. Strategic Outlook - The company plans to continue pursuing strategic acquisitions to capture new business opportunities in the Chinese market, aiming to further strengthen its revenue and profit base [1]. - The company is actively seeking projects with growth potential for acquisition or investment and is in discussions with various parties regarding such opportunities [1].
大成生化科技(00809)议决重新启动长春大合的锅炉翻修项目,并拟通过与合适的EPC 承包商签订EPC合约
智通财经网· 2025-05-23 15:11
Core Viewpoint - The company has decided to restart the boiler renovation project at Changchun Dahe and will select a suitable EPC contractor through a public bidding process to carry out the renovation work [1][2]. Group 1: Project Details - The boiler renovation project at Changchun Dahe will be executed under an EPC contract, which includes project design, procurement, and construction responsibilities for the selected contractor [1]. - The bidding announcement for the EPC contract was issued on May 23, 2025, with the bidding period starting on May 26, 2025, and concluding on June 17, 2025 [1]. Group 2: Financial and Operational Context - Changchun Dahe has maintained normal operations throughout 2024, contributing significantly to the company's revenue [2]. - The existing boiler facilities at Changchun Dahe have been in use for over 20 years, utilizing medium/low-pressure boilers, which are less cost-effective compared to the high-temperature/high-pressure options widely used in China [2]. - The renovation aims to upgrade the boiler systems to reduce costs and enhance market competitiveness, aligning with the company's overall sustainability goals [2].